| Prof. Dr. Axel Kleemann
Frankfurt, Germany Prof. Dr. Axel Kleemann has had a distinguished career in the chemical and pharmaceutical divisions of Degussa AG. From 1987 to 2000, he was a member of the Management Board of ASTA Medica AG with responsibility for Research & Development, Production and Engineering. Axel Kleemann served as Chairman of the Supervisory Board of the German Research Center for Biotechnology, Gesellschaft für Biotechnologische Forschung GBF in Braunschweig from 1993 to 2000. He has been an active Board Member in various organizations and scientific societies, including the German Chemist´s Society (GDCh), the German Pharmaceutical Society (DPhG), the German Industrial Association of Biotechnology (DIB) and the German Society for Chemical Engineering and Biotechnology (DECHEMA). He continues to hold the position of Honorary Professor of Chemistry at the Johann Wolfgang Goethe University in Frankfurt am Main as well as member or Chairman of Supervisory or Scientific Advisory Boards in several companies in the field of Biotechnology and Fine Chemicals. Kleemann is also a member of the Editorial Board of “Ullmanns Encyclopedia of Industrial Chemistry”. | 
| Prof. Dr. Dr. Jürgen Engel
Frankfurt, Germany Prof. Dr. Dr. Jürgen Engel obtained his Ph.D. from the University of Braunschweig in 1975. He joined Degussa in 1976. In 1993 he was appointed head of corporate R&D at ASTA Medica AG, and in the same year received an honorary professorship from TU Dresden. Since 1981 he has also lectured at the University of Regensburg. Since 1990, Jürgen Engel holds the position of an adjunct professor at the School of Pharmacy, University of Regensburg, Germany. He now is appointed Managing Director of Æterna Zentaris GmbH, Frankfurt, Germany, and Executive VP, Chief Scientific Officer, Director of the Board of Æterna Zentaris Inc., Quebec City, Canada. | 
| Prof. Dr. Bernhard Kutscher
Weiterstadt, Germany Prof. Dr. Bernhard Kutscher obtained his Ph.D. on peptide synthesis in 1984 from the University of Frankfurt/Main. He joined DEGUSSA in 1984, becoming head of the medicinal chemistry department at ASTA Medica AG in 1987, and later responsibility for the chemical research of the whole corporation. In 2000 he was appointed as the VP R&D of ASTA Medica Oncology. Today he is General Manager and VP R&D at Baxter Europe, based in Brussels, and Managing Director of Baxter Oncology GmbH, Halle/Germany. Since 1992 he has also lectured at TU Munich and received an honorary professorship in 1996. | 
| Dr. Dietmar Reichert
Frankfurt, Germany Dr. Dietmar Reichert studied and completed a Ph.D. in organic chemistry at the Johann Wolfgang Goethe University of Frankfurt/Main on total synthesis of variotin-fungicides in 1992. After postdoctoral research at Cassella AG he joined the chemical department at ASTA Medica AG in 1994 with responsibility for Combinatorial and Automated Syntheses. In June 2000 he joined Degussa AG at the Hanau-Wolfgang site and was initially working for strategic R&D within the Fine Chemical unit. In 2002 he was appointed Section Manager within the business line "Pharma Intermediates & Exclusive Synthesis". Since 2007 he is responsible for "Strategic projects and Market Intelligence" in Evonik´s business line "Exclusive Synthesis & Catalysts". |
|
